These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2494728)

  • 1. Biological efficacy of a boronated porphyrin as measured in cell culture.
    Laster BH; Kahl SB; Kalef-Ezra J; Popenoe EA; Fairchild RG
    Strahlenther Onkol; 1989; 165(2-3):203-5. PubMed ID: 2494728
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides.
    Fairchild RG; Kahl SB; Laster BH; Kalef-Ezra J; Popenoe EA
    Cancer Res; 1990 Aug; 50(16):4860-5. PubMed ID: 2379150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological efficacy of thermal neutrons using Na2(10)B12H11SH studied in vivo on B-16 mouse melanoma.
    Spryshkova R; Naidenov M; Borisov G; Komkov M; Bratsev V; Serebryakov N; Demidov A
    Strahlenther Onkol; 1989; 165(2-3):213-5. PubMed ID: 2494732
    [No Abstract]   [Full Text] [Related]  

  • 4. Boron determination for neutron capture therapy by colorimetry and emission spectrometry.
    Strouf O; Mertenová E; Schneiderová L; Zámecníková H; Janků I
    Strahlenther Onkol; 1989; 165(2-3):174-6. PubMed ID: 2494723
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced survival in a rat glioma model following BNCT.
    Clendenon NR; Barth RF; Goodman JH; Staubus AE; Gordon WA; Moeschberger ML; Alam F; Soloway AH; Fairchild RG; Slatkin DN
    Strahlenther Onkol; 1989; 165(2-3):222-5. PubMed ID: 2494736
    [No Abstract]   [Full Text] [Related]  

  • 6. Canine spontaneous brain tumors--a large animal model for BNCT.
    Gavin PR; Kraft SL; Wendling LR; Miller DL
    Strahlenther Onkol; 1989; 165(2-3):225-8. PubMed ID: 2494737
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives of the clinical BNCT of malignant gliomas in Czechoslovakia.
    Sourek K; Tovarys F
    Strahlenther Onkol; 1989; 165(2-3):247-9. PubMed ID: 2494741
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative microscopic study on response of Ehrlich carcinoma to BNCT vs. chemo- and radiotherapy.
    Samarrai SF; al-Mufti AW; Hikmat S; Karim JM; al-Hayani R; Sugano H; Saito T; Tsukagoshi S; Amano K; Hatanaka H
    Strahlenther Onkol; 1989; 165(2-3):217-8. PubMed ID: 2494734
    [No Abstract]   [Full Text] [Related]  

  • 9. The incorporation of boronated substances into melanin in vitro--an experimental model for melanotic melanoma.
    Roberto A; Larsson BS
    Strahlenther Onkol; 1989; 165(2-3):165-7. PubMed ID: 2494722
    [No Abstract]   [Full Text] [Related]  

  • 10. Boronated compounds for neutron capture therapy.
    Alam F; Bapat BV; Soloway AH; Barth RF; Mafune N; Adams DM
    Strahlenther Onkol; 1989; 165(2-3):121-3. PubMed ID: 2494714
    [No Abstract]   [Full Text] [Related]  

  • 11. Boronated antibodies for neutron capture therapy.
    Abraham R; Müller R; Gabel D
    Strahlenther Onkol; 1989; 165(2-3):148-51. PubMed ID: 2494718
    [No Abstract]   [Full Text] [Related]  

  • 12. Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia.
    Tamat SR; Patwardhan A; Moore DE; Kabral A; Bradstock K; Hersey P; Allen BJ
    Strahlenther Onkol; 1989; 165(2-3):145-7. PubMed ID: 2494717
    [No Abstract]   [Full Text] [Related]  

  • 13. Conjugation, purification and characterization of boronated monoclonal antibodies for use in neutron capture therapy.
    Barth RF; Mafune N; Alam F; Adams DM; Soloway AH; Makroglou GE; Oredipe OA; Blue TE; Steplewski Z
    Strahlenther Onkol; 1989; 165(2-3):142-5. PubMed ID: 2494716
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy.
    Mill AJ
    Strahlenther Onkol; 1989; 165(2-3):193-6. PubMed ID: 2494726
    [No Abstract]   [Full Text] [Related]  

  • 15. Fast neutrons from the Essen cyclotron can be used successfully for neutron capture experiments in vitro.
    Ziegler W; Sauerwein W; Streffer C
    Strahlenther Onkol; 1989; 165(2-3):210-2. PubMed ID: 2494731
    [No Abstract]   [Full Text] [Related]  

  • 16. Boronophenylalanine for neutron capture therapy of melanoma.
    Coderre JA; Glass JD; Fairchild RG; Micca P; Kalef-Ezra J
    Strahlenther Onkol; 1989; 165(2-3):215-7. PubMed ID: 2494733
    [No Abstract]   [Full Text] [Related]  

  • 17. Plan for synthesis of biomolecules for neutron capture therapy of cervical carcinoma.
    Wongwiechintana C; Choonchartprasert S; Tampitak S; Prachayasittigul S
    Strahlenther Onkol; 1989; 165(2-3):125-6. PubMed ID: 2494715
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neutron capturing irradiation: principle, current results and perspectives].
    Pignol JP; Chauvel P
    Bull Cancer Radiother; 1995; 82(3):283-97. PubMed ID: 8554878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron chemistry and target cell affinity.
    Soloway AH; Alam F; Barth RF; Bapat BV
    Strahlenther Onkol; 1989; 165(2-3):118-20. PubMed ID: 2494713
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival assays with a boronated porphyrin as measured with hamster V-79 cells in culture.
    Laster BH; Kahl SB; Popenoe EA; Gordon C; Kalef-Ezra J; Fairchild RG
    Basic Life Sci; 1989; 50():213-8. PubMed ID: 2751611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.